Genetic analysis of sporadic and familial interstitial pneumonia

Proceedings of the American Thoracic Society

Volumn 5, Issue 3, 2008, Pages 343-347

  Schwartz, David A ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Familial interstitial pneumonia; Genetics; Pulmonary fibrosis

Indexed keywords

CONFERENCE PAPER; DISEASE COURSE; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; HUMAN; INTERSTITIAL PNEUMONIA; LUNG FIBROSIS; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTOSIS; PROTEIN DEGRADATION; PROTEIN METABOLISM; SURFACE TENSION; TELOMERE;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); LUNG DISEASES, INTERSTITIAL; MICE; POLYMORPHISM, GENETIC;

EID: 42049088309     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200710-158DR     Document Type: Conference Paper

References (70)

1. Javaheri S, Lederer DH, Pella JA, Mark GJ, Levine BW. Idiopathic pulmonary fibrosis in monozygotic twins: the importance of genetic predisposition. Chest 1980;78:591-594.
2. Solliday NH, Williams JA, Gaensler EA, Coutu RE, Carrington C. Familial chronic interstitial pneumonia. Am Rev Respir Dis 1973;108:193-204.
3. Bonanni PP, Frymoyer JW, Jacox RF. A family study of idiopathic pulmonary fibrosis: a possible dysproteinemic and genetically determined disease. Am J Med 1965;39:411-421.
4. Hughes EW. Familial interstitial pulmonary fibrosis. Thorax 1964;19:515-525.
5. Swaye P, van Ordstrand HS, McCormack LJ, Wolpaw SE. Familial Hamman-Rich syndrome. Chest 1969;55:7-12.
6. Bitterman PB, Rennard SI, Keogh BA, Wewers MD, Adelberg S, Crystal RG. Familial idiopathic pulmonary fibrosis: evidence of lung inflammation in unaffected members. N Engl J Med 1986;314:1343-1347.
7. Lee HL, Ryu JH, Wittmer MH, Hartman TE, Lymp JF, Tazelaar HD, Limper AH. Familial idiopathic pulmonary fibrosis: clinical features and outcome. Chest 2005;127:2034-2041.
8. Hodgson U, Laitinen T, Tukiainen P. Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax 2002;57:338-342.
9. Tsukahara M, Kajii T. Interstitial pulmonary fibrosis in two sisters: possible autosomal recessive inheritance. Jinrui Idengaku Zasshi 1983;28:263-267.
10. Adelman AG, Chertkow G, Hayton RC. Familial fibrocystic pulmonary dysplasia: a detailed family study. Can Med Assoc J 1966;95:603-610.
11. McKusick VA, Fisher AM. Congenital cystic disease of the lung with progressive pulmonary fibrosis and carcinomatosis. Ann Internal Med 1958;48:774-790.
12. Musk AW, Zilko PJ, Manners P, Kay PH, Kamboh MI. Genetic studies in familial fibrosing alveolitis: possible linkage with immunoglobulin allotypes (Gm). Chest 1986;89:206-210.
13. Marshall R, Puddicombe A, Cookson W, Laurent G. Adult familial cryptogenic fibrosing alveolitis in the UK. Thorax 2000;55:143-146.
14. Depinho RA, Kaplan KL. The Hermansky-Pudlak syndrome: report of three cases and review of pathophysiology and management considerations. Medicine 1985;64:192-202.
15. Riccardi V. Von Recklinghausen neurofibromatosis. N Engl J Med 1981;305:1617-1627.
16. Makle SK, Pardee N, Martin CJ. Involvement of the lung in tuberous sclerosis. Chest 1970;58:538-540.
17. Harris J, Waltuck B, Swenson E. The pathophysiology of the lungs in tuberous sclerosis: a case report and literature review. Am Rev Respir Dis 1969;100:379-387.
18. Terry R, Sperry W, Brodoff B. Adult lipoidosis resembling Neimann-Pick disease. Am J Pathol 1954;30:263-286.
19. Schneider E, Epstein C, Kaback M, Brandes D. Severe pulmonary involvement in adult Gaucher's disease: report of three cases and review of the literature. Am J Med 1977;63:475-480.
20. Auwerx J, Boogaerts M, Ceuppens JL, Demedts M. Defective host defence mechanisms in a family with hypocalciuric hypercalcaemia and coexisting interstitial lung disease. Clin Exp Immunol 1985;62:57-64.
21. Thomas AQ, Lane K, Phillips J III, Prince M, Markin C, Speer M, Schwartz DA, Gaddipati R, Marney A, Johnson J, et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 2002;165:1322-1328.
22. Polakoff PL, Horn BR, Scherer OR. Prevalence of radiographic abnormalities among Northern California shipyard workers. Ann N Y Acad Sci 1979;33:333-339.
23. Selikoff IJ, Lilis R, Nicholson WJ. Asbestos disease in United States shipyards. Ann N Y Acad Sci 1979;330:293-311.
24. Rossi G, Szapiel S, Ferrans V, Crystal R. Susceptibility to experimental interstitial lung disease is modified by immune- and non-immune related genes. Am Rev Respir Dis 1987;135:448-455.
25. Ortiz LA, Lasky J, Hamilton RF Jr, Holian A, Hoyle GW, Banks W, Peschon JJ, Brody AR, Lungarella G, Friedman M. Expression of TNF and the necessity of TNF receptors in bleomycin- induced lung injury in mice. Exp Lung Res 1998;24:721-743.
26. Corsini E, Luster MI, Mahler J, Craig WA, Blazka ME, Rosenthal GJ. A protective role for T lymphocytes in asbestos-induced pulmonary inflammation and collagen deposition. Am J Respir Cell Mol Biol 1994;11:531-539.
27. 1-induced fibroproliferative lung disease in two strains of mice. Am J Respir Cell Mol Biol 2002;27:705-713.
28. Khalil N, O'Connor RN, Unruh HW, Warren PW, Flanders KC, Kemp A, Bereznay OH, Greenberg AH. Increased production and immunohistochemical localization of transforming growth factor-β in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 1991;5:155-162.
29. Kapanci Y, Desmouliere A, Pache J-C, Redard M, Gabbiani G. Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis: possible role of transforming growth factor β and tumor necrosis factor α. Am J Respir Crit Care Med 1994;152:2163-2169.
30. 1) genotype and lung allograft fibrosis. J Heart Lung Transplant 1999;18:517-523.
31. 1 gene. Transplantation 1998;66:1014-1020.
32. 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 1991;88:6642-6646.
33. Martinet Y, Rom WN, Grotendorst GR, Martin GR, Crystal RG. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N Engl J Med 1987;317:202-209.
34. Shaw R, Benedict SH, Clark RAF, King TE. Pathogenesis of pulmonary fibrosis in interstitial lung disease: alveolar macrophage PDGF(B) gene activation and up-regulation by interferon γ. Am Rev Respir Dis 1991;143:167-173.
35. Nagaoka I, Trapnell BC, Crystal RG. Upregulation of platelet-derived growth factor-A and -B gene expression in alveolar macrophages of individuals with idiopathic pulmonary fibrosis. J Clin Invest 1990;85:2023-2027.
36. Limper AH, Broekelmann TJ, Colby TV, Malizia G, McDonald JA. Analysis of local mRNA expression for extracellular matrix proteins and growth factors using in situ hybridization in fibroproliferative lung disorders. Chest 1991;99:55S-56S.
37. Avila JJ, Lympany PA, Pantelidis P, Welsh KI, Black CM, du Bois RM. Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis. Am J Respir Cell Mol Biol 1999;20:106-112.
38. Bloor CA, Knight RA, Kedia RK, Spiteri MA, Allen JT. Differential mRNA expression of insulin-like growth factor-1 splice variants in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 2001;164:265-272.
39. Whyte M, Hubbard R, Meliconi R, Whidborne M, Eaton V, Bingle C, Timms J, Duff G, Facchini A, Pacilli A, et al. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-α gene polymorphisms. Am J Respir Crit Care Med 2000;162:755-758.
40. Pantelidis P, Fanning GC, Wells AU, Welsh KI, Du Bois RM. Analysis of tumor necrosis factor-α, lymphotoxin-α, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001;163:1432-1436.
41. Freeburn RW, Kendall H, Dobson L, Egan J, Simler NJ, Millar AB. The 3′ untranslated region of tumor necrosis factor-α is highly conserved in idiopathic pulmonary fibrosis (IPF). Eur Cytokine Netw 2001;12:33-38.
42. Hutyrová B, Pantelidis P, Drabek J, Zurkova M, Kolek V, Lenhart K, Welsh KI, Du Bois RM, Petrek M. Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002;165:148-151.
43. Vasakova M, Striz I, Slavcev A, Jandova S, Kolesar L, Sulc J. Th1/Th2 cytokine gene polymorphisms in patients with idiopathic pulmonary fibrosis. Tissue Antigens 2006;67:229-232.
44. Zorzetto M, Ferrarotti I, Trisolini R, Agli LL, Scabini R, Novo M, De Silvestri A, Patelli M, Martinetti M, Cuccia MC, et al. Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003;168:330-334.
45. Awad M, Pravica V, Perrey C, El Gamel A, Yonan N, Sinnott PJ, Hutchinson IV. CA repeat allele polymorphism in the first intron of the human interferon-γ gene is associated with lung allograft fibrosis. Hum Immunol 1999;60:343-346.
46. Elias JA, Freundlich B, Kern JA, Rosenbloom J. Cytokine networks in the regulation of inflammation and fibrosis in the lung. Chest 1990;97:1439-1445.
47. Bienkowski RS, Gotkin MG. Control of collagen deposition in mammalian lung. Proc Soc Exp Biol Med 1995;209:118-140.
48. Gurujeyalakshmi G, Giri SN. Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-β and procollagen I and III gene expression. Exp Lung Res 1995;21:791-808.
49. Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block L. A preliminary study of long-term treatment with interferon γ-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999;341:1264-1269.
50. Marshall RP, McAnulty RJ, Laurent GJ. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med 2000;161:1999-2004.
51. Morrison CD, Papp AC, Hejmanowski AQ, Addis VM, Prior TW. Increased D allele frequency of the angiotensin-converting enzyme gene in pulmonary fibrosis. Hum Pathol 2001;32:521-528.
52. Hojo S, Fujita J, Yamadori I, Kamei T, Yoshinouchi T, Ohtsuki Y, Okada H, Bandoh S, Yamaji Y, Takahara J, et al. Heterogeneous point mutations of the p53 gene in pulmonary fibrosis. Eur Respir J 1998;12:1404-1408.
53. Vassilakis DA, Sourvinos G, Spandidos DA, Siafakas NM, Bouros D. Frequent genetic alterations at the microsatellite level in cytologic sputum samples of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2000;162:1115-1119.
54. 1-Antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis. Lancet 1977;2:1049-1051.
55. 1-Antitrypsin phenotypes, including M subtypes, in pulmonary disease associated with rheumatoid arthritis and systemic sclerosis. Arthritis Rheum 1986;29:586-591.
56. Varpela E, Tiilikainen A, Varpela M, Tukianien P. High prevalences of HLA-B15 and HLA-Dw6 in patients with cryptogenic fibrosing alveolitis. Tissue Antigens 1979;14:68-71.
57. Hakala M, Ruuska P, Hameenkorpi R, Tiilikainen A, Ilonen J, Makitalo R. Diffuse interstitial lung disease in rheumatoid arthritis. Scand J Rheumatol 1986;15:368-376.
58. Libby DM, Gibofsky A, Fotino M, Waters SJ, Smith JP. Immunogenetic and clinical findings in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1983;127:618-622.
59. Wise RA, Wigley FM, Scott TE, Hochberg MC. HLA-DQw allonantigens and pulmonary dysfunction in rheumatoid arthritis. Chest 1988;94:609-614.
60. Falfan-Valencia R, Camarena A, Juarez A, Becerril C, Montano M, Cisneros J, Mendoza F, Granados J, Pardo A, Selman M. Major histocompatibility complex and alveolar epithelial apoptosis in idiopathic pulmonary fibrosis. Hum Genet 2005;118:235-244.
61. Fulmer J, Sposovska M, von Gal E, Crystal R, Mittal K. Distribution of HLA antigens in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1978;118:141-147.
62. Nogee LM, Dunbar AE III, Wert SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001;344:573-579.
63. Lawson WE, Grant SW, Ambrosini V, Womble KE, Dawson EP, Lane KB, Markin C, Renzoni E, Lympany P, Thomas AQ, et al. Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax 2004;59:977-980.
64. Selman M, Lin HM, Montaño M, Jenkins AL, Estrada A, Lin Z, Wang G, DiAngelo SL, Guo X, Umstead TM, et al.: Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis. Hum Genet 2003;113:542-550.
65. Armanios MY, Chen JJ, Cogan JD, Alder JK, Ingersoll RG, Markin C, Lawson WE, Xie M, Vulto I, Phillips JA III, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 2007;356:1317-1326.
66. Kalliopi D, Tsakiri JT, Cronkhite PJ, Kuan CX, Raghu G, Weissler JC, Rosenblatt RL, Shay JW, Garcia CK. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci USA 2007;104: 7552-7557.
67. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-1073.
68. Thompson LM, Plummer S, Schalling M, Altherr MR, Gusella JF, Housman DE, Wasmuth JJ. A gene encoding a fibroblast growth factor receptor isolated from the Huntington disease gene region of human chromosome 4. Genomics 1991;11:1133-1142.
69. Speer M. Genetic linkage: concepts and methods. In: Alberts M, editor. Genetics of cerebrovascular disease. Armonk, NY: Futura Publishing; 1999. pp. 19-40.
70. Hodgson U, Pulkkinen V, Dixon M, Peyrard-Janvid M, Rehn M, Lahermo P, Ollikainen V, Salmenkivi K, Kinnula V, Kere J, et al. ELMOD2 is a candidate gene for familial idiopathic pulmonary fibrosis. Am J Hum Genet 2006;79:149-154.